Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Chesney

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
JAMA Psychiatry|February 2, 2017
Hormonal Contraception and Its Association With DepressionEdward Chesney
The British Journal of Psychiatry : the Journal of Mental Science|September 9, 2017
Improving life expectancy in people with serious mental illness: should we place more emphasis on primary prevention?Athif Ilyas, Edward Chesney, Rashmi Patel
Psychopharmacology|July 13, 2021
Cannabidiol (CBD) as a novel treatment in the early phases of psychosisEdward Chesney, Dominic Oliver, Philip McGuire
Cannabis and Cannabinoid Research|November 16, 2023
Assessing Cannabis Use in People with PsychosisEdward Chesney, Will Lawn, Philip McGuire
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|June 4, 2014
Risks of all-cause and suicide mortality in mental disorders: a meta-reviewEdward Chesney, Guy M Goodwin, Seena Fazel
Bjpsych Bulletin|May 12, 2021
Managing restricted patients in acute, non-secure in-patient services: clinical, ethical and resource implications of long waits for a response from the Ministry of JusticeGunjan Sharma, Penelope Brown, Ijaz Ur Rehman, et al.
Addiction (Abingdon, England)|February 6, 2020
How experimental cannabinoid studies will inform the standardized THC unitLucy Chester, Edward Chesney, Dominic Oliver, et al.
The Journal of Nervous and Mental Disease|January 9, 2016
Pathways to Care for Patients With First-Episode Psychosis in SingaporeEdward Chesney, Edimansyah Abdin, Lye Yin Poon, et al.
Therapeutic Advances in Psychopharmacology|September 25, 2020
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol productsEdward Chesney, Philip McGuire, Tom P Freeman, et al.
Therapeutic Advances in Psychopharmacology|October 31, 2022
Acceptability of cannabidiol in patients with psychosisEdward Chesney, Doga Lamper, Millie Lloyd, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
JAMA Psychiatry|February 2, 2017
Hormonal Contraception and Its Association With DepressionEdward Chesney
The British Journal of Psychiatry : the Journal of Mental Science|September 9, 2017
Improving life expectancy in people with serious mental illness: should we place more emphasis on primary prevention?Athif Ilyas, Edward Chesney, Rashmi Patel
Psychopharmacology|July 13, 2021
Cannabidiol (CBD) as a novel treatment in the early phases of psychosisEdward Chesney, Dominic Oliver, Philip McGuire
Cannabis and Cannabinoid Research|November 16, 2023
Assessing Cannabis Use in People with PsychosisEdward Chesney, Will Lawn, Philip McGuire
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|June 4, 2014
Risks of all-cause and suicide mortality in mental disorders: a meta-reviewEdward Chesney, Guy M Goodwin, Seena Fazel
Bjpsych Bulletin|May 12, 2021
Managing restricted patients in acute, non-secure in-patient services: clinical, ethical and resource implications of long waits for a response from the Ministry of JusticeGunjan Sharma, Penelope Brown, Ijaz Ur Rehman, et al.
Addiction (Abingdon, England)|February 6, 2020
How experimental cannabinoid studies will inform the standardized THC unitLucy Chester, Edward Chesney, Dominic Oliver, et al.
The Journal of Nervous and Mental Disease|January 9, 2016
Pathways to Care for Patients With First-Episode Psychosis in SingaporeEdward Chesney, Edimansyah Abdin, Lye Yin Poon, et al.
Therapeutic Advances in Psychopharmacology|September 25, 2020
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol productsEdward Chesney, Philip McGuire, Tom P Freeman, et al.
Therapeutic Advances in Psychopharmacology|October 31, 2022
Acceptability of cannabidiol in patients with psychosisEdward Chesney, Doga Lamper, Millie Lloyd, et al.
Pageof 5